Overall Infectious Complications Related to Belatacept Conversion in Comparison to Tacrolimus in Kidney Transplant Recipients.

Marvin, Jennifer E; Azar, Marwan M; Belfield, Kristen D; Do, Vincent; Formica, Richard; Cohen, Elizabeth A

Marvin, Jennifer E; Azar, Marwan M; Belfield, Kristen D; Do, Vincent; Formica, Richard; Cohen, Elizabeth A.

Affiliation

Marvin JE; Department of Pharmacy, 25047Yale New Haven Hospital, New Haven, CT, USA.
Azar MM; Section of Infectious Diseases, 12228Yale School of Medicine, New Haven, CT, USA.
Belfield KD; Department of Pharmacy, 25047Yale New Haven Hospital, New Haven, CT, USA.
Do V; Department of Pharmacy, 25047Yale New Haven Hospital, New Haven, CT, USA.
Formica R; Section of Nephrology, Yale School of Medicine, New Haven, CT, USA.
Cohen EA; Department of Pharmacy, 25047Yale New Haven Hospital, New Haven, CT, USA.

Prog Transplant ; 32(4): 351-356, 2022 12.

Article in En | MEDLINE | ID: mdl-36039533

Subject(s)

Kidney Transplantation; Tacrolimus; Humans; Tacrolimus/adverse effects; Abatacept/therapeutic use; Kidney Transplantation/adverse effects; Graft Rejection/drug therapy; Retrospective Studies; Immunosuppressive Agents/adverse effects; Graft Survival; Transplant Recipients

Key words

belatacept; clinical outcomes; immunosuppression; infection; kidney transplant; tacrolimus

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Tacrolimus Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Prog Transplant Journal subject: ENFERMAGEM / TRANSPLANTE Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google